Brain Pet-Mri Systems Market Size & Share Analysis - Growth, Trends, And Forecasts (2025 - 2030)

The Brain PET MRI Report is Segmented by Product (Traditional PET-MRI Systems, Helium-free/Cryogen-free Systems, Fully-Integrated Digital PET-MRI Systems), Phase (Pre-Clinical, Clinical), End User (Hospitals, Diagnostic Imaging Centers, and More), Application (Neurology, and More), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, South America). The Market Forecasts are Provided in Terms of Value (USD).

Brain PET-MRI Systems Market Size and Share

Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Compare market size and growth of Brain PET-MRI Systems Market with other markets in Healthcare Industry

Brain PET-MRI Systems Market Analysis by Mordor Intelligence

The Brain PET MRI market is valued at USD 388.27 million in 2025 and is forecast to reach USD 524.51 million by 2030, advancing at a 6.2% CAGR. Growth stems from the convergence of rising neurological disorder prevalence, breakthroughs in hybrid-imaging technology and expanding reimbursement frameworks that lower financial hurdles for advanced neuroimaging. North America remains the revenue anchor, yet Asia-Pacific is advancing fastest as healthcare systems upgrade diagnostic infrastructure and local manufacturers scale production. Traditional PET-MRI platforms continue to dominate installed bases, but helium-free designs are accelerating as providers seek insulation from supply-chain shocks and long-term operating costs. Clinical oncology presently drives scanner utilization, while neurology procedures surge on the back of amyloid-targeted Alzheimer’s therapies. Across regions, hospitals still initiate most purchases, yet outpatient imaging centers are gaining momentum as scan times fall and compact systems arrive.

Key Report Takeaways

  • By product category, traditional PET-MRI systems held 78.32% of the Brain PET MRI market share in 2024; helium-free solutions are projected to expand at a 6.91% CAGR to 2030. 
  • By phase, clinical applications accounted for 61.25% revenue in 2024, whereas preclinical usage is forecast to climb at a 10.14% CAGR through 2030. 
  • By end user, hospitals led with 54.38% share of the Brain PET MRI market size in 2024; diagnostic imaging centers are expected to register a 10.54% CAGR to 2030. 
  • By application, oncology contributed 45.81% revenue in 2024, while neurology procedures are advancing at a 10.41% CAGR through 2030. 
  • By geography, North America contributed 42.35% revenue in 2024; Asia-Pacific is poised for a 10.87% CAGR, the fastest worldwide.

Segment Analysis

By Product: Traditional Systems Drive Revenue Despite Helium-Free Innovation

Traditional scanners held 78.32% of the Brain PET MRI market in 2024, underscoring buyer preference for clinically validated platforms with extensive regulatory clearance. The Brain PET MRI market size tied to traditional systems is projected to expand from USD 304.1 million in 2025 to USD 403.4 million in 2030 at a 5.7% CAGR. Hospitals cite multipurpose flexibility and seamless protocol libraries as chief benefits, reinforcing the installed-base lock-in effect. 

Helium-free and cryogen-free systems, while accounting for a modest share today, are the fastest-growing category at 6.91% CAGR. Providers value their 97% reduction in helium consumption and 40 MWh annual energy savings, benefits that align with decarbonization mandates. As global helium reserves tighten, the Brain PET MRI market share of helium-free designs is forecast to pass 25% by 2030. Digital detector integration and on-board AI analytics are converging across all form factors, suggesting future competition will pivot on smart-workflow ecosystems rather than pure magnet architecture.

Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

By Phase: Clinical Applications Dominate While Preclinical Research Accelerates

Clinical use generated 61.25% revenue in 2024, propelled by expanded reimbursement, neurologist demand for amyloid confirmation and oncologist reliance on metabolic-anatomical fusion. The Brain PET MRI market size for clinical procedures is expected to rise at a 5.8% CAGR, reflecting rising scan volumes per installed system. Hospitals leverage hybrid imaging to shorten diagnostic odysseys, thereby boosting bed-turnover metrics and attracting tertiary referrals. 

Preclinical adoption, though smaller in absolute dollars, is scaling at a 10.14% CAGR as pharmaceutical companies incorporate PET-MRI biomarkers into go-no-go decisions. Bruker’s dDNP signal-amplification platform delivers 10,000-fold metabolic sensitivity, enabling mouse-to-human translation of drug-response signatures. Research institutes deploy compact animal scanners, which cost a third of clinical units and circumvent radiopharmacy complexities, thereby accelerating discovery while nurturing future clinical protocols.

By End User: Hospital Dominance Faces Imaging-Center Challenge

Hospitals commanded 54.38% revenue in 2024 thanks to integrated nuclear medicine departments, on-site radiotracer production and broad payer contracts. The Brain PET MRI market size attributable to hospital sites is projected to reach USD 296.4 million by 2030. Multi-disciplinary teams favor hybrid imaging for surgical planning conferences and tumor boards, embedding PET-MRI into decision pathways. 

Diagnostic imaging centers, bolstered by 10.54% CAGR, are reshaping competitive dynamics. Lower construction costs for helium-free consoles enable suburban installations where patient access and scheduling flexibility drive referral capture. Teleradiology networks broaden subspecialty coverage, and mobile radiopharmacy partnerships offset tracer-delivery gaps. Academic institutions, meanwhile, cement their niche via grant-funded translational trials that pioneer protocol optimization.

Brain PET-MRI Systems Market: Market Share by End User
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

By Application: Oncology Leadership Yields to Neurology Growth

Oncology remained top with 45.81% revenue in 2024, yet its CAGR of 5.5% trails that of neurology. Surgical teams rely on PET-MRI to delineate glioma margins and differentiate pseudoprogression, supporting precision resections and stereotactic-radiation planning. The Brain PET MRI market share anchored in oncology is forecast to decline marginally as other indications catch up. 

Neurology studies, expanding at 10.41% CAGR, will close the gap by 2030. New disease-modifying Alzheimer’s therapies require amyloid verification, while Parkinson’s trials need dopaminergic-receptor imaging for cohort stratification. Emerging protocols in major depressive disorder and epilepsy further enlarge the neurologic canvas. Cardiology and psychiatric imaging remain exploratory but could accelerate once reimbursement pathways crystallize.

Geography Analysis

North America retained 42.35% share in 2024, fueled by Medicare policy expansion, NIH grant pipelines and vendor–academic collaborations such as GE HealthCare’s joint AI projects with UCSF and Stanford Medicine [3]“GE HealthCare Collaborates with UCSF and Stanford,” GE HealthCare News, gehealthcare.com. The Brain PET MRI market size in the region is forecast to surpass USD 220 million by 2030. Yet helium-reserve privatization ignites cost-volatility concerns, prompting providers to fast-track helium-free upgrades. 

Asia-Pacific is the fastest-growing territory with a 10.87% CAGR. Japan’s national image repository underpins algorithm development, while China’s multi-decade healthcare reform funnels capital toward tertiary neuro centers, albeit with lingering rural-urban gaps. Domestic OEMs now supply gradient coils and RF amplifiers, shortening lead times and lowering price points, further propelling Brain PET MRI market adoption. 

Europe exhibits mature uptake; however, the 2024 EU approval of Lecanemab triggers a surge in amyloid scans, enhancing utilization rates. Sustainability policies accelerate adoption of helium-light systems, and cross-border data-sharing aligns protocol standards. South America and the Middle East & Africa are nascent but benefit from public-private diagnostic-center joint ventures that import refurbished scanners and leverage international teleradiology expertise.

Brain PET-MRI Systems Market CAGR (%), Growth Rate by Region
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Competitive Landscape

The Brain PET MRI market is moderately consolidated, led by Siemens Healthineers, GE HealthCare and Philips, each differentiating via technology roadmaps rather than price. Siemens markets virtually helium-free magnets and eco-designs that slash energy draw by 30%. GE focuses on AIR™ coil arrays and AI-powered workflow orchestration, underscored by its acquisition of MIM Software to deepen quantitative-image analytics. Philips partners with NVIDIA to embed transformer-based models that automate scan planning and reduce operator variance. 

Second-tier players such as Bruker and MR Solutions target research and preclinical niches with ultra-high-resolution detectors. Cubresa’s removable BrainPET insert exemplifies modular add-ons that retrofit into existing MRI suites, a strategy appealing to budget-constrained centers. Vendors increasingly bundle lifetime-software licenses and remote-service diagnostics, creating recurring-revenue streams and deepening customer lock-in. 

Strategic alliances characterize recent moves: Siemens collaborates with biotech firms to co-develop tau-imaging tracers, while Philips engages hospital networks in outcome-based contracting where payment aligns to throughput and uptime metrics. The race to on-device AI fosters ecosystem thinking; vendors open software-development kits to third-party algorithm creators, ensuring platform stickiness and data-network effects that reinforce competitive moats.

Brain PET-MRI Systems Industry Leaders

  1. Siemens Healthineers AG

  2. Koninklijke Philips N.V.

  3. GE HealthCare

  4. Bruker

  5. Mediso Ltd.

  6. MR Solutions

  7. Cubresa Inc.

  8. Aspect Imaging Ltd.

  9. *Disclaimer: Major Players sorted in no particular order
Brain PET-MRI Systems Market Concentration
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Need More Details on Market Players and Competitors?
Download PDF

Recent Industry Developments

  • February 2024: Philips introduced Smart Quant Neuro 3D, an AI-based quantitative brain-MRI package that streamlines workflow and enhances diagnostic confidence.
  • June 2023: GE HealthCare unveiled SIGNA PET/MRI AIR technologies at the Society of Nuclear Medicine and Molecular Imaging annual meeting in Canada.
  • May 2023: Cubresa installed its first BrainPET insert system at St. Joseph’s Health Care London in partnership with Lawson Health Research Institute.

Table of Contents for Brain PET-MRI Systems Industry Report

1. Introduction

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope of the Study

2. Research Methodology

3. Executive Summary

4. Market Landscape

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence Of Neurological Disorders
    • 4.2.2 Rapid Advancements In Hybrid-Imaging Technology
    • 4.2.3 Supportive Government Funding Programs
    • 4.2.4 Growing Demand For PET-MRI In Neuro-Oncology
    • 4.2.5 AI-Enabled Quantitative Neuro-Biomarker Integration
    • 4.2.6 Use In Neuro-Psychiatric Drug-Trial Stratification
  • 4.3 Market Restraints
    • 4.3.1 High Capital & Maintenance Costs
    • 4.3.2 Limited Accessibility In Low-Income Regions
    • 4.3.3 Workflow-Integration & Training Complexity
    • 4.3.4 Helium Supply-Chain Vulnerability
  • 4.4 Value / Supply-Chain Analysis
  • 4.5 Regulatory Landscape
  • 4.6 Technological Outlook
  • 4.7 Porter’s Five Forces Analysis
    • 4.7.1 Threat of New Entrants
    • 4.7.2 Bargaining Power of Buyers
    • 4.7.3 Bargaining Power of Suppliers
    • 4.7.4 Threat of Substitutes
    • 4.7.5 Competitive Rivalry

5. Market Size & Growth Forecasts (Value – USD)

  • 5.1 By Product
    • 5.1.1 Traditional PET-MRI Systems
    • 5.1.2 Helium-free / Cryogen-free Systems
    • 5.1.3 Fully-integrated Digital PET-MRI Systems
  • 5.2 By Phase
    • 5.2.1 Pre-clinical
    • 5.2.2 Clinical
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Diagnostic Imaging Centers
    • 5.3.3 Academic & Research Institutes
  • 5.4 By Application
    • 5.4.1 Neurology
    • 5.4.2 Oncology
    • 5.4.3 Cardiology
    • 5.4.4 Psychiatry
  • 5.5 By Geography
    • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
    • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle East & Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East & Africa
    • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6. Competitive Landscape

  • 6.1 Market Concentration
  • 6.2 Market Share Analysis
  • 6.3 Company Profiles (includes Global-level Overview, Market-level Overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, Recent Developments)
    • 6.3.1 Siemens Healthineers AG
    • 6.3.2 Koninklijke Philips N.V.
    • 6.3.3 GE HealthCare Technologies Inc.
    • 6.3.4 Bruker Corporation
    • 6.3.5 Mediso Ltd.
    • 6.3.6 MR Solutions
    • 6.3.7 Cubresa Inc.
    • 6.3.8 Aspect Imaging Ltd.
    • 6.3.9 United Imaging Healthcare Co., Ltd.
    • 6.3.10 Canon Medical Systems Corp.
    • 6.3.11 Hitachi Ltd.
    • 6.3.12 Shenzhen Anke High-tech Co.
    • 6.3.13 MILabs B.V.
    • 6.3.14 Time Medical Systems
    • 6.3.15 Positron Corp.
    • 6.3.16 LabLogic Systems Ltd.
    • 6.3.17 HyperProbe LLC
    • 6.3.18 Thermo Fisher Scientific Inc.
    • 6.3.19 Trifoil Imaging
    • 6.3.20 Unisyn Medical

7. Market Opportunities & Future Outlook

  • 7.1 White-space & Unmet-Need Assessment
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Global Brain PET-MRI Systems Market Report Scope

The PET/MRI scan combines positron emission tomography (PET) and magnetic resonance imaging (MRI) into one test. This hybrid technology produces highly detailed images of the body. Doctors use these images to diagnose conditions and plan treatments. These scans help in the diagnosis of Alzheimer's disease, epilepsy, and brain tumors.

The brain PET-MRI systems market is segmented into product, phase, end-user, and geography. By product, the market is segmented into traditional brain PET-MRI systems and Helium-free PET-MRI systems. By phase, the market is segmented into pre-clinical and clinical. By end-user, the market is segmented into hospitals, diagnostic imaging centers and other end users. By geography the market is segmented into North America, Europe, Asia-Pacific, and Rest of the World. The report also offers the market size and forecasts for 13 countries across the region. For each segment, the market sizing and forecasts have been done on the basis of value (USD).

By Product Traditional PET-MRI Systems
Helium-free / Cryogen-free Systems
Fully-integrated Digital PET-MRI Systems
By Phase Pre-clinical
Clinical
By End User Hospitals
Diagnostic Imaging Centers
Academic & Research Institutes
By Application Neurology
Oncology
Cardiology
Psychiatry
By Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa GCC
South Africa
Rest of Middle East & Africa
South America Brazil
Argentina
Rest of South America
By Product
Traditional PET-MRI Systems
Helium-free / Cryogen-free Systems
Fully-integrated Digital PET-MRI Systems
By Phase
Pre-clinical
Clinical
By End User
Hospitals
Diagnostic Imaging Centers
Academic & Research Institutes
By Application
Neurology
Oncology
Cardiology
Psychiatry
By Geography
North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa GCC
South Africa
Rest of Middle East & Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Key Questions Answered in the Report

How big is the Brain PET-MRI Systems Market?

The Brain PET-MRI Systems Market size is expected to reach USD 388.27 million in 2025 and grow at a CAGR of 6.20% to reach USD 524.51 million by 2030.

Which application segment is growing fastest?

Neurology procedures are expanding at a 10.41% CAGR, propelled by Alzheimer’s and Parkinson’s imaging needs

Who are the key players in Brain PET-MRI Systems Market?

Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare, Bruker, Mediso Ltd., MR Solutions, Cubresa Inc. and Aspect Imaging Ltd. are the major companies operating in the Brain PET-MRI Systems Market.

Which is the fastest growing region in Brain PET-MRI Systems Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Brain PET-MRI Systems Market?

North America leads with 42.35% revenue in 2024, thanks to robust reimbursement and research funding.

Page last updated on: July 7, 2025